Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

Stopped early · Phase 2

Conditions studied: Erectile Dysfunction

In brief

The purpose of this study is to assess the safety \& efficacy of a single dose of alprostadil cream with 2 concentrations of WC3036 compared to vehicle alone in men with erectile dysfunction.

Key facts

Study ID

NCT01810575

Run by

Warner Chilcott

People needed

16

Starts

2013-02-01

Expected to finish

2013-04-01

Last updated by the study team

2014-08-12

Who can join

Age: 40 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Male subject aged 40 or older of any race
• History of ED (erectile dysfunction) of at least 3 months duration defined as inability to attain \& maintain an erection of the penis sufficient to permit satisfactory sexual intercourse
• Completed and signed informed consent prior to any study related procedures

You may not qualify if…

• History/presence any significant disease that Investigator feels will interfere with course of the study
• Anatomic deformity of penis
• History/presence alcoholism or drug abuse/dependence within past 2 years (discretion of Investigator)
• Participation in investigational study drug trial within 30 days prior to randomization

Where it is running

• Warner Chilcott Investigational Study Site — Purchase, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.